Report: Malaysia tested 'controversial' drug without harm to Covid-19 patients


KUALA LUMPUR: Amid a controversy relating to the use of hydroxychloroquine on Covid-19 patients, Malaysia found a way to test the anti-malaria drug on patients of the respiratory disease without harming them, says a report.

Based on interviews recorded for the report "The Malaysian Response to Covid-19: Building Preparedness for ‘Surge Capacity’, Testing Efficiency, and Containment", Malaysia relied on Chinese expertise which found that lower doses of the drug were effective, while monitoring closely for heart issues and acknowledging the need for high quality evidence.

Get 30% off with our ads free Premium Plan!

Monthly Plan

RM13.90/month
RM9.73 only

Billed as RM9.73 for the 1st month then RM13.90 thereafters.

Annual Plan

RM12.33/month
RM8.63/month

Billed as RM103.60 for the 1st year then RM148 thereafters.

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In Nation

More than 8,000 absent
Johor’s Chingay parade will be rerouted this year
Rising costs still a burden for farmers even with new floor price
Jail, caning for child sex abuse at tahfiz school
Anti-smoking groups demand stricter vape enforcement
‘Do better by healthcare workers’
‘Passion, patience and lots of love’
Young bomoh pleads guilty to sexually abusing girl
PM’s official visits abroad crucial to boost diplomatic ties
Trader charged with cheating comedian’s wife

Others Also Read